Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy

Malignant glioma is an aggressive brain cancer that responds poorly to chemotherapy. However, the molecular mechanism underlying the development of chemoresistance in glioma is not well-understood. In this study, we show that long non-coding RNA AC023115.3 is induced by cisplatin in human glioblastoma cells and that elevated AC023115.3 promotes cisplatin-induced apoptosis by inhibiting autophagy. Further mechanistic studies revealed that AC023115.3 acts as a competing endogenous RNA for miR-26a and attenuates the inhibitory effect of miR-26a on GSK3 beta, a proline-directed serine-threonine kinase that promotes the degradation of Mcl1, leading to an increase in GSK3 beta and a decrease in autophagy. Additionally, we discovered that AC023115.3 improves chemosensitivity of glioma cells to cisplatin by regulating the miR-26a-GSK3 beta-Mcl1 pathway. Thus, these data indicate that the AC023115.3-miR-26a-GSK3 beta signalling axis plays an important role in reducing the chemoresistance of glioma.